These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7801672)

  • 1. [Recommendation for the introduction of the International Normalized Ratio as an objective measure for the dosage of oral anticoagulant therapy].
    Horstkotte D; Hohnloser S; Keller F; Kolde HJ; Müller-Beissenhirtz W; Taborski U; Webering F
    Z Kardiol; 1994 Sep; 83(9):676-9. PubMed ID: 7801672
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of a chromogenic factor X assay with international normalized ratio for monitoring oral anticoagulation therapy.
    McGlasson DL; Romick BG; Rubal BJ
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):513-7. PubMed ID: 18685434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
    Crowther MA
    Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is the international normalized ratio (INR) indispensable in clinical practice?].
    Witt I
    Dtsch Med Wochenschr; 1994 Nov; 119(45):1529-31. PubMed ID: 7956786
    [No Abstract]   [Full Text] [Related]  

  • 5. [Role of laboratory monitoring in oral anticoagulant therapy].
    D'Angelo G; Calvano D; Giardini C
    Minerva Med; 1993 Jun; 84(6):313-22. PubMed ID: 8336839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monitoring blood coagulation].
    Pabinger-Fasching I
    Wien Med Wochenschr; 1999; 149(2-4):70-1. PubMed ID: 10378328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of oral anticoagulant therapy.
    Fairweather RB; Ansell J; van den Besselaar AM; Brandt JT; Bussey HI; Poller L; Triplett DA; White RH
    Arch Pathol Lab Med; 1998 Sep; 122(9):768-81. PubMed ID: 9740135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monitoring of oral anticoagulant therapy in Norway--recommendations for transfer to the INR system].
    Sandset PM
    Tidsskr Nor Laegeforen; 1998 Sep; 118(22):3443-5. PubMed ID: 9800495
    [No Abstract]   [Full Text] [Related]  

  • 9. [Oral anticoagulant treatment].
    Melis Tormos E
    Rev Enferm; 2009 May; 32(5):48-54. PubMed ID: 19552155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of oral anticoagulant treatment in patients with venous thromboembolism.
    Pengo V
    Semin Thromb Hemost; 2006 Nov; 32(8):781-6. PubMed ID: 17171590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recommendations for prevention of thromboembolism in heart valve diseases. Working Group on Valvular Heart Disease, European Society of Cardiology].
    Gohlke-Bärwolf C; Acar J; Oakley C; Butchart E; Burckhardt D; Delahaye JP; Horstkotte D; Bodnar E; Hall R; Kremer R
    Z Kardiol; 1995 Dec; 84(12):1018-32. PubMed ID: 8578786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral anticoagulant therapy in subjects with congenital or acquired thrombophilia.
    Baglin T
    Semin Vasc Med; 2003 Aug; 3(3):315-22. PubMed ID: 15199465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term oral anticoagulation. Evidence favors self management].
    Westphal K
    MMW Fortschr Med; 2004 Oct; 146(42):58-9. PubMed ID: 15536709
    [No Abstract]   [Full Text] [Related]  

  • 14. Laboratory monitoring of oral anticoagulant therapy.
    Poller L; Samama M
    Clin Lab Med; 1994 Dec; 14(4):813-23. PubMed ID: 7874873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: introduction.
    Brandt JT
    Arch Pathol Lab Med; 1998 Sep; 122(9):765-6. PubMed ID: 9740134
    [No Abstract]   [Full Text] [Related]  

  • 16. Interaction between hormone replacement therapy preparations and oral anticoagulant therapy.
    McLintock LA; Dykes A; Tait RC; Walker ID
    BJOG; 2003 Aug; 110(8):777-9. PubMed ID: 12892692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient self-management of oral anticoagulation.
    Fancher TL; White RH
    Curr Hematol Rep; 2004 Sep; 3(5):368-74. PubMed ID: 15341705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality assessment in point-of-care coagulation testing.
    Kitchen DP; Kitchen S; Jennings I; Woods T; Walker I
    Semin Thromb Hemost; 2008 Oct; 34(7):647-53. PubMed ID: 19085765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the international normalized ratio?
    Tripodi A; Arbini AA; Chantarangkul V; Bettega D; Mannucci PM
    Thromb Haemost; 1993 Dec; 70(6):921-4. PubMed ID: 8165612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International sensitivity index calibration of the near-patient testing prothrombin time monitor, ProTime.
    Tripodi A; Chantarangkul V; Bressi C; Mannucci PM
    Am J Clin Pathol; 2003 Feb; 119(2):241-5. PubMed ID: 12579994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.